`
`http://www.accessdata.fda.gov/drugsatfda_docs/NDA/98/viagra/viagra_t...
`
`FDA Home3 Drugs4 Drug Approvals and Databases5 Drugs@FDA6
`Drug Approval Package
`
`Viagra (sildenafil citrate)
`Company: Pfizer
`Application No.: 020895
`Approval Date: 3/27/1998
`Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for
`assistance.
`FDA's Clinical, Statistical and Biopharmacological Review of Viagra Clinical Development
`Cover Sheet (PDF) (3/27/1998)1.
`
`
`Joint Clinical Reviews (3/27/1998)
`2.
`A. Table of Contents (PDF)
`B. Sections 1-6 (PDF)
`C. Section 7 (PDF)
`D. Section 8 (PDF)
`E. Section 9-10 (PDF)
`F. Appendix A, Sections 1-4 (PDF)
`G. Appendix A, Sections 5-9 (PDF)
`H. Appendix A, Sections 10-13 (PDF)
`I. Appendix A, Sections 14-22 (PDF)
`J. Appendix A, Sections 23-33 (PDF)
`K. Appendix A, Sections 34-43 (PDF)
`L. Appendix A, Sections 44-51 (PDF)
`M. Appendix A, Sections 52-56 (PDF)
`
`
`
`Chemistry Review (PDF) (3/27/1998)3.
`
`Pharmacology Reviews (3/27/1998)
`4.
`A. Review and Evaluation of Pharmacology and Toxicology Data, Pages 1-25 (PDF)
`B. Review and Evaluation of Pharmacology and Toxicology Data, Pages 26-48 (PDF)
`C. Review and Evaluation of Pharmacology and Toxicology Data, Pages 49-65 (PDF)
`D. Review and Evaluation of Pharmacology and Toxicology Data, Pages 66-90 (PDF)
`E. Review and Evaluation of Pharmacology and Toxicology Data, Pages 91-116 (PDF)
`F. Review and Evaluation of Pharmacology and Toxicology Data, Pages 117-142 (PDF)
`Statistical Carcinogenicity Reviews (3/27/1998)
`5.
`A. Carcinogenicity Review of Sildenafil in Rats and Mice (PDF)
`B. Appendix A, Male Rats (PDF)
`C. Appendix B, Female Rats (PDF)
`D. Appendix C, Male Mice (PDF)
`E. Appendix D, Female Mice (PDF)
`
`Carcinogenicity Assessment Committee and FDA/CDER Rodent Carcinogenicity Database Factsheet6.
`(PDF) (3/27/1998)
`
`
`
`Administrative Documents (PDF) (3/27/1998)7.
`
`
`
`Correspondence (PDF) (3/27/1998)8.
`
`Date created: March 27, 1998
`
`Back to Top Drugs@FDA7
`
`1 of 2
`
`10/31/2016 11:08 AM
`
`ATI 1019-0001
`
`ATI v. COS
`IPR2018-01183
`
`
`
`Drug Approval Package: Brand Name (Generic Name) NDA #
`
`http://www.accessdata.fda.gov/drugsatfda_docs/NDA/98/viagra/viagra_t...
`
`Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for
`assistance.
`Note: Documents in PDF format require the Adobe Acrobat Reader®8.
`
`Links on this page:
`http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain1.
`
`
`http://www.addthis.com/bookmark.php2.
`
`http://www.fda.gov/default.htm3.
`
`http://www.fda.gov/Drugs/default.htm4.
`
`http://www.fda.gov/Drugs/InformationOnDrugs/default.htm5.
`
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm6.
`
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm7.
`
`http://get.adobe.com/reader/8.
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewer
`and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain1.
`
`
`http://www.addthis.com/bookmark.php2.
`
`http://www.fda.gov/default.htm3.
`
`http://www.fda.gov/Drugs/default.htm4.
`
`http://www.fda.gov/Drugs/InformationOnDrugs/default.htm5.
`
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm6.
`
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm7.
`
`http://get.adobe.com/reader/8.
`
`2 of 2
`
`10/31/2016 11:08 AM
`
`ATI 1019-0002
`
`